Literature DB >> 8963729

Endothelium-dependent and -independent vasodilation of large arteries in normoalbuminuric insulin-dependent diabetes mellitus.

J Lambert1, M Aarsen, A J Donker, C D Stehouwer.   

Abstract

Vascular complications in diabetes mellitus are associated with endothelial dysfunction. Whether endothelium-dependent vasodilation is impaired in normoalbuminuric patients with insulin-dependent diabetes mellitus (IDDM) is controversial. Using a noninvasive echo-Doppler method, we investigated endothelium-dependent and endothelium-independent vasodilation in the brachial artery of IDDM patients. There were 52 normoalbuminuric and normotensive patients with IDDM (aged 31.9 +/- 9.8 years; diabetes duration, 14.9 +/- 7.9 years; glycated hemoglobin, 7.9 +/- 1.2%) and 52 healthy control group (C) subjects comparable for age and sex studied. Brachial artery diameter was measured at baseline, during postocclusion reactive hyperemia (flow-mediated, endothelium-dependent dilation [FMD]), and after 400 micrograms glyceryl trinitrate (GTN) sublingually (endothelium-independent vasodilation). Vasodilation was expressed as the percentage change relative to the baseline diameter. Baseline flow and blood pressure were similar for IDDM patients and C. Baseline vessel diameter was slightly larger in IDDM patients (3.10 +/- 0.52 mm) compared with C (2.89 +/- 0.55 mm, P = 5.0). FMD in IDDM patients was decreased (12.0 +/- 9.1% versus 15.7 +/- 9.5% in C, P = .046), as was GTN-induced vasodilation (14.9 +/- 8.2% versus 18.3 +/- 8.5% in C, P = .045). After correction for the difference in baseline diameter, FMD and GTN-induced dilation were not different between the groups. GTN-induced vasodilation decreased slightly with increasing diabetes duration. There was no relation between the vasodilatory responses and HbA1c. In normoalbuminuric IDDM patients, endothelium-dependent as well as endothelium-independent vasodilation are normal when the difference in baseline diameter is taken into account.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8963729     DOI: 10.1161/01.atv.16.5.705

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  19 in total

Review 1.  Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.

Authors:  Rokhsana Mortuza; Subrata Chakrabarti
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 2.  Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes.

Authors:  Marcello C Bertoluci; Gislaine V Cé; Antônio Mv da Silva; Marco V Wainstein; Winston Boff; Marcia Puñales
Journal:  World J Diabetes       Date:  2015-06-10

Review 3.  Endothelial dysfunction in diabetes.

Authors:  A S De Vriese; T J Verbeuren; J Van de Voorde; N H Lameire; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

Review 4.  Vascular reactivity in diabetes mellitus.

Authors:  Ajay Chaudhuri
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

Review 5.  Endothelial dysfunction in human diabetes.

Authors:  Sari Mäkimattila; Hannele Yki-Järvinen
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

6.  Renal functional reserve in patients with Type 1 diabetes mellitus.

Authors:  Jelka Zaletel; Darko Cerne; Katarina Lenart; Sabine Zitta; Günther Jürgens; Willibald Estelberger; Andreja Kocijancic
Journal:  Wien Klin Wochenschr       Date:  2004-04-30       Impact factor: 1.704

7.  Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria.

Authors:  L Sibal; A Aldibbiat; S C Agarwal; G Mitchell; C Oates; S Razvi; J U Weaver; J A Shaw; P D Home
Journal:  Diabetologia       Date:  2009-05-30       Impact factor: 10.122

Review 8.  Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide.

Authors:  Lisa Kitasato; Taiki Tojo; Yuko Hatakeyama; Ryo Kameda; Takehiro Hashikata; Minako Yamaoka-Tojo
Journal:  Cardiovasc Diabetol       Date:  2012-06-29       Impact factor: 9.951

9.  Miglitol improves postprandial endothelial dysfunction in patients with acute coronary syndrome and new-onset postprandial hyperglycemia.

Authors:  Daisuke Kitano; Masaaki Chiku; Yuxin Li; Yasuo Okumura; Daisuke Fukamachi; Tadateru Takayama; Takafumi Hiro; Satoshi Saito; Atsushi Hirayama
Journal:  Cardiovasc Diabetol       Date:  2013-06-19       Impact factor: 9.951

Review 10.  Cellular signaling and potential new treatment targets in diabetic retinopathy.

Authors:  Zia A Khan; Subrata Chakrabarti
Journal:  Exp Diabetes Res       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.